Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Bridget Koontz, MD, FASTRO

AdventHealth Cancer Institute
Durham, NC

Dr. Koontz trained at Harvard Medical School, UNC-Chapel Hill, and Duke University School of Medicine, and was tenured faculty at Duke Cancer Institute from 2007 to 2021. She led the US oncology network for GenesisCare, a leading global oncology organization for two years, where she drove key national and global initiatives to enhance and improve the operational experience of physicians and the quality of care for patients. She is now supporting research development and education at East Carolina University. Her interests are in promoting excellent care for patients with genitourinary malignancies, and research to improve both the treatment of and recovery from cancer. She has frequently been faculty at ASTRO and ASCO GU meetings, and has published over 100 articles, chapters, and books, was an associate senior editor for International Journal of Radiation Oncology Biology Physics (2015 -2018) and the senior editor of the practical handbook Radiation Therapy Treatment Effects: An Evidence-Based Guide to Managing Toxicity (2017). She has conducted translational laboratory research developing models of radiation-induced pelvic toxicity, has led phase I and phase II trials in prostate cancer, and is the national PI of NRG-GU011, a trial of stereotactic radiotherapy for oligometastatic prostate cancer. She continues to investigate clinical efforts to improve the quality of life of cancer survivors through technology such as eHealth apps and activity trackers. She currently represents radiation oncology as a member of the NCI’s Genitourinary Steering Committee for NCTN trials.

Disclosures:

  • Employment: Duke University School of Medicine:Associate Professor:Employee;East Carolina University:Affiliate Professor:Independent Contractor;Nova Southeastern University:Consultant:Independent Contractor;UNC-Chapel Hill:Adjunct Associate Professor:Independent Contractor
  • Compensation: Blue Earth Diagnostics: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 5/30/2023 ;Lantheus: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria, Travel Expenses-End Date: 5/12/23 ;Rythera Therapeutics: Consultant, Grant Research Funding, Compensation Payment-End Date: present ;Mirrors of Medicine: Compensation Payment-End Date: 3/1/2023 ;Merck: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 6/30/2021
  • Ownership: Rythera Therapeutics:Ownership Equity
  • Leadership: IHE-RO:Co-Chair;IJROBP:Associate Editor;NRG Oncology:Co-Chair

Presentation(s):